Abbott UK

Abbott has a proud history of working with patient organisations in Europe and throughout the world.

Patient organisations provide valuable information and support to patients and to the people that care for them, such as family and friends. We believe that we can support these organisations in their efforts to help patients understand and manage their disease.

Abbott's relationships with patient organisations are based on trust, respect and mutual benefit. We aim for transparency and high ethical standards in all of our relationships.

We learn about issues of concern to patients and together, look for ways to address them in the best possible way. By building sustainable relationships we also work towards advancing dialogue around healthcare issues and together, can seek ways to ensure optimal delivery of healthcare.

Our support to patient organisations takes the forms of event/programme support, organisational support, patient education and caregiver education.

Abbott's Support (Financial and Non-Financial) of Patient Organisations

January 2011 - December 2011
Name of Patient Organisation Abbott Business Nature of Support Financial / Non-financial Support Monetary Value of Support* (£)
African Eye TrustProprietary Pharmaceuticals DivisionPatient education, non collaborativeFinancial3,000
African Health Policy NetworkProprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial10,000
Arthritis CareProprietary Pharmaceuticals DivisionProgramme support, collaborativeNon Financial44,700
Arthritis CareProprietary Pharmaceuticals DivisionProgramme support, collaborativeNon Financial40,000
Arthritis Care (Northern Ireland)Proprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial650
Arthritis and Musculoskeletal Alliance (ARMA)Proprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial15,000
Arthritis and Musculoskeletal Alliance (ARMA)Proprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
BlissProprietary Pharmaceuticals DivisionCaregiver education, non collaborativeFinancial40,000
Crohn's and Colitis UKProprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial20,000
Crohn's and Colitis UKProprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial1,860
Crohn's and Colitis UKProprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
Guildford Whipples Patient Support GroupEstablished Pharmaceuticals DivisionEvent support, non collaborativeFinancial850
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial930
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial20,000
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial25,000
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial10,000
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
National Ankylosing Spondylitis Society (NASS)Proprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial25,000
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial2,500
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, collaborativeNon-financial42,814
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial1,860
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, collaborativeNon-financial44,700
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial1,000
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, collaborativeNon-financial40,000
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial460
National Rheumatoid Arthritis Society (NRAS)Proprietary Pharmaceuticals DivisionProgramme support, non collaborativeFinancial920
National Kidney Federation (NKF)Proprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial2,000
National Kidney Federation (NKF)Proprietary Pharmaceuticals DivisionProgramme support, collaborativeNon-financial600
National AIDS TrustProprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial15,000
NAM (National AIDS Manual)Proprietary Pharmaceuticals DivisionPatient education, non collaborativeFinancial5,000
Parkinson's UKEstablished Pharmaceuticals DivisionProgramme support, collaborativeFinancial10,000
Patients AssociationAbbott Nutrition InternationalProgramme support, non collaborativeFinancial45,000
Patients AssociationAbbott Nutrition InternationalProgramme support, non collaborativeFinancial1,100
Psoriasis AssociationProprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial1,000
Psoriasis AssociationProprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial1,500
Psoriasis AssociationProprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial1,860
Psoriasis AssociationProprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial500
Psoriasis Scotland Arthritis Link Volunteers (PSALV)Proprietary Pharmaceuticals DivisionEvent support, collaborativeFinancial390
Psoriasis Scotland Arthritis Link Volunteers (PSALV)Proprietary Pharmaceuticals DivisionOrganisational support, non collaborativeFinancial3,000
Positively UKProprietary Pharmaceuticals DivisionEvent support, non collaborativeFinancial2,924
Positively UKProprietary Pharmaceuticals DivisionProgramnme support, non collaborativeFinancial10,000
TinyLifeProprietary Pharmaceuticals DivisionProgramnme support, non collaborativeFinancial5,000
Support initiated prior to 2011
Age UKAbbott Nutrition InternationalEvent SupportFinancial30,000
The Patient AssociationAbbott Nutrition InternationalOrganisational SupportFinancial8,000
BLISSProprietary Pharmaceuticals DivisionEvent SupportFinancial-
BLISSProprietary Pharmaceuticals DivisionCaregiver EducationFinancial30,000
NACCProprietary Pharmaceuticals DivisionEvent SupportFinancial63,460
HIV i-BaseProprietary Pharmaceuticals DivisionPatient EducationFinancial8,000
BLISSProprietary Pharmaceuticals DivisionCaregiver EducationFinancial-
African HIV Policy Network (AHPN)Proprietary Pharmaceuticals DivisionOrganisational SupportFinancial-
National AIDS Trust (NAT)Proprietary Pharmaceuticals DivisionEvent SupportFinancial-
The Food ChainProprietary Pharmaceuticals DivisionEvent SupportFinancial-
Waverley Care ScotlandProprietary Pharmaceuticals DivisionPatient EducationFinancial-
Terrance Higgins Trust (THT)Proprietary Pharmaceuticals DivisionPatient EducationFinancial16,000
AB PlusProprietary Pharmaceuticals DivisionPatient EducationFinancial-
*For activities commenced on or after 01 May 2011 or ongoing on that date.

Event/Programme support - An event or programme conducted or attended by the patient organisation, which is sponsored by Abbott, whether in whole or in part.

Patient Education - An educational programme directed at patients, which is sponsored by Abbott, whether in whole or in part.

Organisational Support - Funding for infrastructure or general programme (e.g. websites, facilities, etc.)

Caregiver Education - An educational programme directed at patient caregivers, which is sponsored by Abbott, whether in whole or in part.